Evaluation of survival extrapolation in immuno-oncology using multiple pre-planned data cuts: learnings to aid in model selection
Bullement, Ash, Willis, Anna, Amin, Amerah, Schlichting, Michael, Hatswell, Anthony James, Bharmal, Murtuza
Published in BMC medical research methodology (06.05.2020)
Published in BMC medical research methodology (06.05.2020)
Get full text
Journal Article
Retrospective analysis of real-world treatment patterns and clinical outcomes in patients with advanced non-small cell lung cancer starting first-line systemic therapy in the United Kingdom
Lester, Jason, Escriu, Carles, Khan, Sarah, Hudson, Emma, Mansy, Talal, Conn, Andrew, Chan, Samuel, Powell, Ceri, Brock, Juliet, Conibear, John, Nelless, Lauren, Nayar, Vaneet, Zhuo, Xiaohui, Durand, Adeline, Amin, Amerah, Martin, Peter, Zhang, Xinke, Pawar, Vivek
Published in BMC cancer (07.05.2021)
Published in BMC cancer (07.05.2021)
Get full text
Journal Article
Real-world use of cladribine tablets (completion rates and treatment persistence) in patients with multiple sclerosis in England: The CLARENCE study
Brownlee, Wallace, Amin, Amerah, Ashton, Luke, Herbert, Alex
Published in Multiple sclerosis and related disorders (01.11.2023)
Published in Multiple sclerosis and related disorders (01.11.2023)
Get full text
Journal Article
Real-World Evidence with Five-Year Data (2017-2022) on the Use of Cladribine Tablets in Patients with Multiple Sclerosis in England: an Updated Analysis from the CLARENCE Study
Brownlee, Wallace, Amin, Amerah, Ashton, Luke, Herbert, Alex
Published in Multiple sclerosis and related disorders (01.12.2023)
Published in Multiple sclerosis and related disorders (01.12.2023)
Get full text
Journal Article
Real-World Use of Cladribine Tablets (Completion Rates and Treatment Persistence) in Patients with Multiple Sclerosis in England: the CLARENCE Study
Brownlee, Wallace, Amin, Amerah, Ashton, Luke, Herbert, Alex
Published in Multiple sclerosis and related disorders (01.03.2023)
Published in Multiple sclerosis and related disorders (01.03.2023)
Get full text
Journal Article
131 Understanding the administration and monitoring time burden of several disease-modifying therapies for relapsing multiple sclerosis
Rog, David, Brownlee, Wallace, Carod-Artal, Francisco Javier, Kalra, Seema, Cock, Erwin De, Leclerc, Stephanie, Amin, Amerah, Ashton, Luke, Evans, Hannah
Published in Journal of neurology, neurosurgery and psychiatry (01.09.2022)
Published in Journal of neurology, neurosurgery and psychiatry (01.09.2022)
Get full text
Journal Article
Cost–effectiveness analysis for avelumab first-line maintenance treatment of advanced urothelial carcinoma in Scotland
Critchlow, Simone, Bullement, Ash, Crabb, Simon, Jones, Robert, Christoforou, Katerina, Amin, Amerah, Xiao, Ying, Kapetanakis, Venediktos, Benedict, Ágnes, Chang, Jane, Kearney, Mairead, Eccleston, Anthony
Published in Future oncology (London, England) (01.03.2024)
Published in Future oncology (London, England) (01.03.2024)
Get full text
Journal Article
Predicting overall survival in patients (pts) with treatment-naive metastatic Merkel cell carcinoma (mMCC) treated with avelumab
Bullement, Ash, D'Angelo, Sandra P., Amin, Amerah, Stapelkamp, Ceilidh, Willis, Anna, Lilley, Cameron, Hatswell, Anthony, Bharmal, Murtuza
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
Quantifying the administration and monitoring time burden of several disease-modifying therapies for relapsing multiple sclerosis in the United Kingdom: A time and motion study
Rog, David, Brownlee, Wallace, Carod-Artal, Francisco Javier, Kalra, Seema, Barker, Noreen, Lowndes, Claire, Pendlebury, Jessica, Leclerc, Stephanie, Amin, Amerah, Ashton, Luke, Evans, Hannah, De Cock, Erwin
Published in Multiple sclerosis and related disorders (01.02.2024)
Published in Multiple sclerosis and related disorders (01.02.2024)
Get full text
Journal Article
Cost Effectiveness of Avelumab for Metastatic Merkel Cell Carcinoma
Bullement, Ash, Nathan, Paul, Willis, Anna, Amin, Amerah, Lilley, Cameron, Stapelkamp, Ceilidh, Hatswell, Anthony, Pescott, Chris, Bharmal, Murtuza
Published in PharmacoEconomics - open (01.09.2019)
Published in PharmacoEconomics - open (01.09.2019)
Get full text
Journal Article